5:57 PM
Jun 11, 2010
 |  BC Extra  |  Company News

MenHibrix receives complete response

FDA issued a complete response letter for a BLA from GlaxoSmithKline plc (LSE:GSK;...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >